ICD-10-CM Billable Code

M11.8

Other specified crystal arthropathies

Clinical Classification Guidelines

Medical Intelligence & Overview

ICD-10 code M11.8 refers to specific types of crystal-related joint diseases that do not fall under more common categories like gout or calcium pyrophosphate deposition disease. These conditions involve the formation of crystals within joint tissues, causing inflammation and pain. Although less common and more specialized, understanding this condition can help patients better grasp their diagnosis and potential management options.

Causes & Symptoms

Clinical Causes: Presence of abnormal crystal formation in joint tissues, which can develop due to various metabolic or environmental factors. Metabolic disorders that alter the balance of minerals and compounds in the body, leading to crystal formation. Repeated joint stress or injury, facilitating crystal deposition. Genetic predispositions affecting crystal solubility or immune responses to crystals. Certain medications or substances that influence mineral metabolism or crystal formation.

Key Symptoms: Joint pain that may worsen with movement or during flare-ups. Swelling and tenderness localized around affected joints. Reduced joint mobility, stiffness, especially after periods of rest or inactivity. Redness and warmth over the joint areas. In some cases, tophi—small nodules composed of crystal deposits—may be visible under the skin. Possible systemic symptoms like fatigue or malaise during active episodes.

Diagnostic & Treatment

Diagnosis Path: Diagnosing other specified crystal arthropathies involves a combination of clinical evaluation and laboratory tests. Often, healthcare providers will perform joint aspiration to extract synovial fluid, which can be examined under a microscope for crystals. Imaging studies such as X-rays or ultrasounds may help identify joint damage or crystal deposits. Blood tests may also be used to assess underlying metabolic causes or rule out other conditions.

Treatment Protocols: Nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce pain and inflammation. Colchicine, which can help prevent crystal deposits and manage flare-ups. Corticosteroid injections directly into affected joints to control severe inflammation. Lifestyle modifications such as dietary adjustments to reduce intake of certain purine-rich foods or minerals associated with crystal formation. Ensuring proper hydration to help dissolve crystals and promote their elimination. Treating underlying metabolic conditions or disorders contributing to crystal deposition. In some cases, surgical intervention may be necessary to remove large crystal deposits or damaged tissue.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M11.8 a billable ICD-10 code?
Yes, M11.8 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M11.8?
Clinical documentation must specify the nature of Other specified crystal arthropathies and any associated comorbidities for accurate reporting.

Cite this Clinical Reference